# Surface glycosaminoglycans mediate adherence between HeLa cells and Lactobacillus salivarius Lv72

Rebeca Martín, Carla Martin, Susana Escobedo, Juan E. Suárez, Luis M. Quiros

► To cite this version:

Rebeca Martín, Carla Martin, Susana Escobedo, Juan E. Suárez, Luis M. Quiros. Surface glycosaminoglycans mediate adherence between HeLa cells and Lactobacillus salivarius Lv72. BMC Microbiology, 2013, 13, 10.1186/1471-2180-13-210. [https://doi.org/10.1186/1471-2180-13-210](https://doi.org/10.1186/1471-2180-13-210). [hal-02643933](https://hal.inrae.fr/hal-02643933)

HAL Id: hal-02643933

https://hal.inrae.fr/hal-02643933

Submitted on 28 May 2020

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
# Surface glycosaminoglycans mediate adherence between HeLa cells and *Lactobacillus salivarius* Lv72

Rebeca Martín¹,², Carla Martín¹,², Susana Escobedo¹,², Juan E Suárez¹,²,³ and Luis M Quirós¹,<fnref n="4" />*

**Abstract**

**Background:** The adhesion of lactobacilli to the vaginal surface is of paramount importance to develop their probiotic functions. For this reason, the role of HeLa cell surface proteoglycans in the attachment of *Lactobacillus salivarius* Lv72, a mutualistic strain of vaginal origin, was investigated.

**Results:** Incubation of cultures with a variety of glycosaminoglycans (chondroitin sulfate A and C, heparin and heparan sulfate) resulted in marked binding interference. However, no single glycosaminoglycan was able to completely abolish cell binding, the sum of all having an additive effect that suggests cooperation between them and recognition of specific adhesins on the bacterial surface. In contrast, chondroitin sulfate B enhanced cell to cell attachment, showing the relevance of the stereochemistry of the uronic acid and the sulfation pattern on binding. Elimination of the HeLa surface glycosaminoglycans with lyases also resulted in severe adherence impairment. Advantage was taken of the *Lactobacillus*-glycosaminoglycans interaction to identify an adhesin from the bacterial surface. This protein, identified as a soluble binding protein of an ABC transporter system (OppA) by MALDI-TOF/(MS), was overproduced in *Escherichia coli*, purified and shown to interfere with *L. salivarius* Lv72 adhesion to HeLa cells.

**Conclusions:** These data suggest that glycosaminoglycans play a fundamental role in attachment of mutualistic bacteria to the epithelium that lines the cavities where the normal microbiota thrives, OppA being a bacterial adhesin involved in the process.

**Keywords:** Proteoglycans, Glycosaminoglycans, Vaginal *Lactobacillus*, Epithelial cell cultures

**Background**

The vaginal microbiota of healthy women of reproductive age is dominated by lactobacilli. Their proportion in this habitat is consistently higher than 70%, in some cases being practically exclusive [1-3]. The evidence compiled about the mutualistic role of lactobacilli on the mucous membranes, together with their harmlessness, has promoted their use as probiotic agents [4]. Isolates obtained from feces, vaginal exudates and even mucous membranes resulting from surgery, have been tested for epithelial adherence, acid, bacteriocin and H₂O₂ production and lack of transmissible antibiotic resistances with the aim of

understanding the basis of their interaction with the mucosal surfaces and, ultimately, using them as probiotic agents [1,2].

Adherence to the epithelium of the cavity to be colonized is of paramount importance to compete with colonization by potential pathogens and to avoid sweeping by the circulating fluids. Impairment of adherence by treatment of microbial or epithelial cells with proteases, lipases or periodic acid suggested that the bacterial adhesins and cellular receptors are proteins, lipids or polysaccharides respectively [5-8]. Furthermore, identification of the proteins secreted by the bacteria and those anchored to its cell wall has provided lists of polypeptides putatively involved in mucous adherence. Curiously, this approach has identified enzymes related to sugar catabolism, such as glyceraldehyde-3-phosphate dehydrogenase and enolase [9-12].

<footnote>* Correspondence: quirosluis@uniovi.es
¹Área de Microbiología, Universidad de Oviedo, Julián Clavería 6 33006 Oviedo, Spain</footnote>

<footnote n="4">⁴Instituto Univesitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain</footnote>

<footnote>Full list of author information is available at the end of the article</footnote>
Cellular receptors that bind bacteria have to be both
ubiquitous on the surface of the epithelial cells while
showing enough variability as to account for the ob-
served organotropism shown. These conditions are met
by proteoglycans (PGs), which are made up of specific
protein cores covalently bound to linear polysaccharides
named glycosaminoglycans (GAGs). The GAGs are built
of repeat disaccharide subunits, whose composition al-
lows their classification into different groups: i) heparin/
heparan sulphate (HS), containing glucuronic acid (GlcA)
and N-acetyl glucosamine (GlcNAc); ii) chondroitin/der-
matan sulphate (CS/DS), where GlcA is replaced by N-
acetylgalactosamine (GalNAc); iii) keratan sulphate, with
galactose and GlcNAc, and iv) hyaluronic acid (HA), with
the same disaccharide unit as HS, but unmodified and
devoid of the protein stem.

During their biosynthesis, all GAGs but HA undergo
different modification reactions that can involve N-de
acetylations, epimerizations and various O-sulfations.
The structure of the GAG chains expressed is regulated
and dynamically adapted. To perform this task, multiple
isoenzymes can perform the catalysis [13-15]. Each iso-
enzyme shows particular substrate specificity, and their
expression vary depending on the cells, the tissues, the
state of development and the physiological and patho-
logical conditions.

A variety of functions have been ascribed to PGs, in-
cluding cell adhesion and migration, organization of the
cytoskeleton and of the extracellullar matrix (ECM), regu-
lation of proliferation, differentiation and morphogenesis,
and tissue repair and inflammation [16-18]. Furthermore,
they act as co-receptors for multiple soluble ligands in-
cluding cytokines, chemokines, growth factors, enzymes
and enzyme inhibitors, thus collaborating in intercellular
communication and tissue differentiation [16,19,20].

PGs in general and especially those with heparan sul-
phate (HSPGs) have been proposed as the receptors that
facilitate recognition and binding between eukaryotic
membranes and microbial pathogens, including bacteria,
viruses and protozoa. Their role as receptors for *Neisseria
meningitidis* [21], *N. gonorrhoeae* [22,23], *Mycobacterium
tuberculosis* [24], *Enterococcus faecalis* [25], *Listeria mono
cytogenes* [26], *Streptococcus* and *Staphylococcus* [27], *Bru-
cella* [28], *Escherichia coli* [29] and even intracellular para-
sites such as *Chlamidia pneumoniae* [30] have been
described. Besides this, it seems that binding of group A
streptococci to GAGs leads to a cytoskeleton conform-
ational change that allows pathogen penetration [31,32].
The requirement of GAGs for viral infection has been dem-
onstrated, among others, for papilloma virus [33], herpes
virus [34], and HIV [35]. Finally, it is known that GAGs
act as receptors for *Toxoplasma gondii* [36], *Leishmania*
[37] and *Plasmodium* [38]. However, the microbial li-
gands involved in most of these processes have not yet

been identified. This role of PGs as the eukaryotic recep-
tors for many pathogens is the basis of our initial hypoth-
esis which suggests the same function of these molecules
when interacting with autochthonous no pathogenic mi-
croorganisms such as lactobacilli.

In this report we provide data on the involvement of
GAGs in attachment of *Lactobacillus salivarius* Lv72, iso-
lated from a human vaginal exudate, to cultures of HeLa
cells. Based on these data, a bacterial adhesin was identi-
fied which, once purified, significantly interfered with
attachment of the lactobacilli to HeLa cell cultures.

Results

Interference of GAGs on HeLa cell-*Lactobacillus salivarius*
Lv72 adhesion

To study the role of GAGs on Lv72 adhesion to HeLa
cells, addition of commercial preparations of HS, heparin,
CS A or CS C to HeLa to cell monolayers was performed
immediately before the addition of exponentially growing
*L. salivarius* Lv72 cells. The results showed a decrease in
the adherence between them (Figure 1). This depletion, al-
though being dose dependent, does not follow a linear cor-
relation. The estimated dissociation constants (K_D) were of
2.5 nM for HS, 6.8 nM for CS A, 39.9 nM for CS C and
280.9 nM for heparin, which indicates that the affinity of
the bacteria for the different receptors varied markedly, up
to two orders of magnitude between HS and heparin.
However, care must be taken with this interpretation, as
the K_Ds are approximate values. Surprisingly, CS B did not
produce any inhibitory effect, and even promoted a slight
increase in the adhesion (Figure 1). Remarkably, the
combined use of these GAGs dramatically increased the
inhibition, reaching values up to 85% and 90% at total
concentrations of 10 and 100 µg/ml respectively, al-
though this effect was not strictly additive (Figure 1A).

Effect of cell surface GAGs digestion on adherence

To investigate further the adherence of Lv72 to the GAGs,
cell surface GAGs were removed by digestion with bacter-
ial lyases, and the effect of this treatment on the binding
of the bacteria was determined. Treatment with chon-
droitinase ABC, which degrades the three CS variants,
resulted in reduced binding (Figure 2), slightly lower than
that observed for high concentrations of the GAGs in
the competition experiment. Furthermore, the concur-
rent degradation of heparan sulfate with heparinase I,
which cleaves at the linkages between hexosamines and
O-sulfated iduronic acids, heparinase III, which cleaves
at the linkages between hexosamine and glucuronic acid,
and heparinase II, which cleaves with lower selectivity link-
ages between hexosamines and uronic acid residues (both
glucuronic and iduronic), resulted in a decrease in binding
comparable to that obtained in competition experiments
(Figure 2). Moreover, the simultaneous degradation with
<figure><img src="image_2.png" /><figcaption>**Figure 1** Inhibition of *Lactobacillus* attachment to HeLa cells by the presence of different GAGs. **A)** Adhesion of *Lactobacillus salivarius* Lv72 to HeLa cells co-incubated in the presence of different concentrations of heparin (♦), HS (.), CS A (■), CS C (□), CS B (▲) and a mixture of all GAGs except CS B (final concentration) (●). **B)** Detail of the inhibitory effect at concentrations below 1 µg/ml. n=9 ANOVA test **, p-value < 0.001; *, p-value < 0.05 vs adhesion of *Lactobacillus salivarius* Lv72 to HeLa cells without interferences.</figcaption></figure>

chondroitinase and heparinases produced an additive effect that reduced the binding of the bacteria (Figure 2).

## Differential effect of GAGs obtained from different cell types on adherence interference

To study the influence of the cellular type, GAGs were extracted from HeLa and HT-29 cell cultures and used in adherence assays. The results showed that the molecules isolated from human epithelial cells inhibited the binding of the lactobacilli more efficiently than commercially available GAGs, from pig or beef tissues (Figure 3A). GAGs from HT-29 and HeLa cultures were three and ten times more effective than the heterologous ones. Finally, soluble HS and CS purified from HeLa cells have similar effects on the adhesion of *L. salivarius* Lv 72 to HeLa cells (Figure 3B).

## Identification and testing of bacterial adhesins able to bind GAGs

To identify the bacterial proteins involved in the interaction between *L. salivarius* Lv72 and eukaryotic GAGs, the proteins of the bacterial envelope were solubilised and subjected to affinity chromatography, using heparin as the ligand. The fractions eluting at concentrations higher than 0.8 M NaCl were tested for their ability to interfere with the HeLa – *L. salivarius* binding. Those showing high activity were subjected to anion exchange chromatography. One of the fractions recovered showed a high interfering activity while presenting just one conspicuous protein band upon SDS-PAGE analysis (Figure 4). This protein was identified by MALDI-TOF (MS) analysis as a soluble binding protein of an ABC transport system due to

its homology with the protein OppA of *Lactobacillus salivarius* UCC118 (GI/90962668) (9 queries matched, 10% sequence coverage). The gene encoding for *L. salivarius* Lv72 OppA was cloned in *E. coli*, overexpressed and purified by passage through a heparin affinity column. The purified protein was used in interference adhesion assays (Figure 5). The results obtained show that OppA significantly interferes with the attachment of *L. salivarius* Lv72 to HeLa cultures in a dose dependent way, thus confirming its role as an adhesin in the interaction between both cellular types.

## Discussion

PGs are ubiquitous, being present in all cell types and in the ECM. The enormous structural diversity of their GAG chains and core proteins mediates specific interactions between many molecules. Because of these characteristics, they play an essential role in the interaction between cells. In addition, these molecules present properties which suggest that they might be part of the receptors that allow the attachment of the normal microbiota to the mucous epithelia that line the digestive tract and the vagina. In fact, many pathogenic microorganisms use these molecules as specific receptors and in bacterial internalization during the infective process [39,40].

### The GAGs are involved on HeLa cell-*Lactobacillus salivarius* Lv72 adhesion

To test the probiotic bacteria-PG receptor hypothesis, a model was devised that involved HeLa cells, a line derived from human genital epithelium, and a vaginal strain of *Lactobacillus salivarius*, which was previously shown to
<figure><img src="image_3.png" /><figcaption>**Figure 2** Effect of the pre-treatment of HeLa cell cultures with GAG lyases on attachment of *L. salivarius* Lv72. HeLa cells were treated with heparinases, chondroitinase ABC or heparinises + chondroitinase ABC before the co-incubation with the lactobacilli. *n*=9 ANOVA test **, p-value < 0.001; *, p-value < 0.05.</figcaption></figure>

adhere to HeLa cells [1]. However, caution should be taken when interpreting these results, as HeLa cell line has been found to be unstable and its gene expression profiles differ from those in normal human tissues [41].

The experiments involved the GAGs HS, CS A, and CS C, usually present on the cell surface as part of PGs such as syndecans, glypicans, betaglycan or different iso-forms of CD44. Heparin (an oversulfated form of HS) and CS B (DS) were also included in the studies. The results indicate that all these GAGs with the exception of CS B were able to efficiently interfere with *L. salivarius* binding, the effect ranging between 50% and 60% for heparin and CS A and C respectively. Their combined effects were nearly additive, the mixture of all species rising to 90% inhibition of the bacterial binding. These data were confirmed by the

observation that enzymatic elimination of surface GAGs resulted in blockage of *L. salivarius* attachment to the HeLa cell cultures.

However, residual attachment always remained after GAG interference or digestion suggesting that other eukaryotic receptors may be involved. In fact, cell-associated ECM proteins such as fibronectin, laminin and collagen have been identified as receptors, especially for pathogenic bacteria [42-44] and also for vaginal and intestinal lactobacilli [45,46]. In addition, direct binding between lactobacilli and glycolipids of the epithelial cell membranes appear to contribute to the attachment, in a process mediated by divalent cations [47]. Finally, non-specific factors might also contribute to cell to cell adherence, especially superficial hydrophobicity established between membrane exposed patches of the eukaryotic cell and components of the Gram positive cell wall, especially teichoic acids [48].

**_L. salivarius_ Lv 72 has different affinity for the different GAGs**

In spite of the general effect of GAGs on bacterial attachment, different molecules displayed apparent disparate interference constants. Among the group of CSs, characterized by being composed of uronic acid linked to the third carbon of N-acetylgalactosamine, CS C appears to be 6 times more active than CS A. Conversely, CS B generated a binding increase. This might be due to the different sulfation patterns shown; CS A and C are sulfated at C-4 and C-6 of the GalNAc moieties respectively, while CS B is usually more extensively sulfated (Figure 6). Additionally, the GlcA residue present in CS A and C is epimerized to IdoA in CS B, which confers greater conformational flexibility on the molecule [49]. The glucosaminoglycans are represented by HS and heparin and are composed of uronic acid linked to the fourth carbon of glucosamine. In spite of their fundamental similarity, heparin displays an apparent affinity that is lower than that of HS. The main difference between these two molecules is that HS displays IdoA rich regions of very high sulfation that can extend from two to eight disaccharide units and are separated by 15 poorly sulfated GlcA rich disaccharide moieties [50]. Heparin, on the other hand, shows more extensive sulfation and uronic acid epimerization (Figure 6). Taken together, these data indicate that the regiochemistry of the sulfation is crucial for affinity of the binding as evidenced by the difference between the CS sulfated at C-4 or C-6, or the significant difference between the oversulfated heparin and the HS. Furthermore, the epimerization of the uronic acid seems also to be crucial, based on the difference in behavior induced by IdoA-rich species, such as heparin and, particularly, CS B.

The high affinity of particular bacteria for HS and heparin has been observed with several pathogens. For instance,
<figure><img src="image_4.png" /><figcaption>**Figure 3** Inhibition of *L. salivarius* attachment to HeLa cells by the presence of GAGs of different origins. A) Relative adherence of the lactobacilli to HeLa cells co-incubated in the presence of 100 µg/ml of total GAGs extracted from HeLa and HT-29 cells and from commercially available, heterologous sources; n=9 ANOVA test **, p-value < 0.001; *, p-value < 0.05. B) Adhesion of *L. salivarius* Lv72 to HeLa cells co-incubated in the presence of increasing concentrations of HS (X), CS (▲) and a mixture of both (♦) extracted from HeLa cell cultures, n=9 ANOVA test **, p-value < 0.001; *, p-value < 0.05 vs adhesion of *Lactobacillus salivarius* Lv72 to HeLa cells without interferences.</figcaption></figure>

both molecules bind strongly to *Pneumococci*, *Penicillium*, *Enterococci* and *Listeria* [25,51-53]. Conversely, heparin displays greater affinity for *Chlamydia* [54] while HS does so for *Pseudomonas* [55]. The CSs are high affinity receptors for *Pneumococci* [53] or *Spirochetes* [56] although they do not bind to *Chlamydia*, *Penicillium*, *Pseudomonas* or *Listeria* [51,52,54,55]. Interestingly, DS usually shows a different behavior compared to other molecular forms of galactosaminoglycans, acting as receptor in *Chlamydia*, *Penicillium* or *Leptospira* [52,54,57], although, to our knowledge, this is the first communication on an increase of bacterial binding in the presence of this molecule in solution.

### The GAGs obtained from different cell types have different effect on adherence

The fine structure of the GAGs differs according not only to their nature, but also to the developmental phase and the physiological and pathological conditions as well as to the cellular type. This is especially noticeable for HS, but also for CS/DS [50,58,59]. GAGs isolated from HeLa and HT-29 cells notably increased the inhibition of binding in comparison to the commercial forms, which were isolated from bovine kidney (HS), bovine trachea (CS A), shark cartilage (CS C) and porcine mucosa (CS B).

### OppA protein is an adhesin involved in Lv 72 adhesion to HeLa cells

Once the nature of the main eukaryotic cell receptors was known, identification of bacterial adhesins became easier because the prior could be employed as affinity ligands for the latter. In this way, using heparin as ligand, we identified OppA, which strongly interfered with HeLa - L.

*salivarius* attachment in a concentration dependent manner. However, a plateau was reached which suggests that other adhesins may exist and that they recognize non-overlapping receptors as happens with *Borrelia burgdorferi*, which presents 4 adhesins capable of GAG binding [56].

OppA is an externally exposed extracellular lipoprotein carrying a peptidase II signal for covalent anchoring to the membrane [12] to which diverse roles have been ascribed; it acts as the substrate-binding protein of the oligopeptide transport system in lactobacilli [60], but has also been implicated in cytoadhesion of *Mycobacterium hominis* and *Treponema denticolaria* to eukaryotic cells through interaction with plasminogen and fibronectin respectively [61-63]. Furthermore, it has been found to interact with fibronectin and collagen in *Lactobacillus casei* BL23 and other OppA orthologues from lactobacilli such as MapA from *L. reuteri* are able to interact with Caco-2 [12,64]. The OppA-mediated cytoadhesion of *M. hominis* to HeLa cells seems to be dependent on the ATPase activity of the protein [63,65]. These precedents and the data reported here on adhesion to GAGs, indicate that OppA is a multifunctional protein that mediates the interaction of the bacteria with its environment. Attachment to the substrate may be a means of accessing peptides that will subsequently be internalized [66], especially for multiauxotrophic organisms such as the lactobacilli.

### Conclusion

In conclusion, the adherence of *L. salivarius* Lv72 to HeLa cells is, at least in part, mediated by the interaction
<figure><img src="image_5.png" /></figure>

<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /></figure>

<figure><img src="image_9.png" /></figure>

<figure><img src="image_10.png" /><figcaption>**Figure 4** Surface proteins of *Lactobacillus salivarius* Lv72 separated by means of heparin-affinity chromatography (A, C, E) and ionic interchange chromatography (B, D, F). **A,B)** Chromatograms. The mark shows the fractions of interest that were tested further. **C,D)** Adherence interference experiments: inhibitory effect of the fractions on Lv72 binding to HeLa cells. **E,F)** SDS-PAGE of the isolated fractions. n=6 ANOVA test **, p-value < 0.001.</figcaption></figure>

of the bacterial OppA protein and the GAGs present on
the eukaryotic surface.

Methods

Bacterial strains, eukaryotic cell lines and growth conditions

*Lactobacillus salivarius* Lv72 (CECT 8259) (*Colección Española de Cultivos Tipo* (CECT), Valencia, Spain) was isolated from the vaginal fluid of a healthy woman of reproductive age [1]. It was propagated in MRS broth (Becton, Franklin lakes, USA) set at 37°C without agitation in a 10% (v/v) CO₂ enriched atmosphere. When

appropriate, 1.5% (w/v) agar was added to the liquid
medium.

HeLa (ATCC CCL-2) and HT-29 (ATCC HTB-38) cell lines (LGC-Standards, Molsheim, France) were grown in Dulbecco's Modified Eagle's minimal essential medium (DMEM) (GibcoBRL, Eragny, France) supplemented with 10% (w/v) fetal bovine serum (GibcoBRL) and with penicillin G/streptomycin (5000 IU/ml, 5000 µg/ml) (Sigma-Aldrich Chemie GmbH, Buchs, Switzerland). Cultures were incubated in 25 cm² tissue culture flasks (Nunc, Roskilde, Denmark) at 37°C in a 5% (v/v) CO₂ atmosphere until
<figure><img src="image_11.png" /><figcaption>**Figure 5** Inhibition of *L. salivarius* Lv72 attachment to HeLa cells by different concentrations of purified OppA. Lv72 was co-incubated in the presence of OppA (■) or bovine serum albumin (used as a negative control) (grey square). n=5 ANOVA test *, p-value < 0.05.</figcaption></figure>

confluence. For adhesion assays, 2000 cells per well were seeded in 24-well culture plates (Nunc) and cultivated, with a daily change of the culture medium until confluence.

## Fluorescein labeling

Fluorescein isothiocyanate (FITC) (Sigma-Aldrich) labeling was performed on overnight cultures washed four times with PBS buffer (GibcoBRL) and resuspended in a 0.1 mg/ml FITC solution to an A600 of 0.5; incubation in the dark at 37°C under agitation proceeded for 2 h and the bacterial suspensions were centrifuged and washed 4 times with PBS to eliminate the excess FITC.

## Adherence assays

Adhesion of *L. salivarius* Lv72 to HeLa monolayers was tested following the procedure described by Tallon and co-workers using 25 FITC-labelled bacteria per eukaryotic cell [67]. At the end of the experiment, epithelial cells were disaggregated with trypsin and the fluorescence of the lac-tobacilli attached to them was quantified in a Perkin Elmer LS55 fluorometer set at 488 nm (excitation) and 560 nm (emission). Data were normalized using the adhesion values without any additive which was given the arbitrary value of 1. Assays were performed at least in triplicate and the data are expressed as the mean ± SD.

Adherence interference experiments were performed with heparin, HS, CS A, CS B (DS) and CS C (Sigma-Aldrich) and their combinations at concentrations ranging between 0.01 and 100 µg/ml (final concentration), added to the monolayers immediately before the bacterial cultures. Complementarily, the surface GAGs of HeLa and HT-29 cells and the bacterial surface proteins of *L. salivarius* Lv72

as well as OppA were extracted and purified (see below) and also used in adherence interference experiments. The dissociation constant estimations were obtained through a non-linear regression using the program Statistica (StatSoft, Inc. USA) by means of the equation of Langmuir [68].

## Enzymatic digestion of eukaryotic cell-surface GAGs

Hydrolysis of HS from cell cultures was achieved by overnight incubation at 37°C in DMEM minimal medium with a mix of 500 mU/ml (final concentration) of each heparinases I, II and III (Sigma-Aldrich). Elimination of CS/DS was obtained through incubation of the cell cultures with 250 mU/ml of chondroitinase ABC (Sigma-Aldrich) at 37°C for 3 h. Elimination of both GAGs was achieved through successive incubation of the cell cultures with the enzymatic mixes, with an intermediate washing with PBS buffer. The reactions were stopped with 2 washes in PBS buffer and the cell cultures were immediately submerged in DMEM and subjected to adherence assays with *L. salivarius* Lv72 as described in a previous paragraph.

## GAG extraction and purification

HeLa and HT-29 cells were propagated in 10 cm diameter tissue plates (Nunc) until confluence. The monolayers were washed twice with PBS and incubated in 6 ml of a 6 M guanidinium chloride, 3 mM DTT (Sigma-Aldrich) solution in 50 mM Tris-HCl (pH 8) at 60°C for 1 h with agitation. Afterwards, 15 ml of a 6.7 mM CaCl₂ (Merck, Lion, France) solution in Tris-HCl (pH 8) plus 1.5 µg/ml proteinase K (Sigma-Aldrich) were added and the culture supernatant was recovered and incubated overnight at 56°C. Subsequently, the proteinase K was inactivated by incubation at 100°C for 10 min; 5.7 volumes of ethanol (VWR) were added followed by incubation at 4°C for 2 h. The precipitated GAGs were pelleted at 4000 x g for 15 min, air-dried and resuspended in 1 ml of a 0.2 M NaOH, 0.8% sodium borohydride (Merck) solution and agitated overnight at room temperature. The resulting suspension was centrifuged at 12,000 x g and the GAGs present in the supernatant were precipitated with ethanol (85%), dried and resuspended in 1 ml distilled water. The GAG concentration was determined spectrophotometrically as described previously [69]. The partial digestion of HS and CS was performed as described above.

## Extraction of *L. salivarius* Lv72 surface proteins and heparin-affinity chromatography

*L. salivarius* Lv72 was grown until mid-exponential phase, washed twice with buffer A (50 mM Tris-HCl, 150 mM NaCl; pH 7.5) and the bacterial cell pellet was resuspended in the same buffer containing a commercial cocktail of EDTA-free protease inhibitors (Roche, Basel, Switzerland), 1 mM MgCl₂, 5 mg/ml lysozyme (Sigma-Aldrich) and 0.05
Chondroitin sulfate A

<figure><img src="image_12.png" /><figcaption>-GlcA(β1-3)GalNAc(β1-4)-</figcaption></figure>

Chondroitin sulfate C

<figure><img src="image_13.png" /><figcaption>-GlcA(β1-3)GalNAc(β1-4)-</figcaption></figure>

Dermatan sulfate

<figure><img src="image_14.png" /><figcaption>-IdoA(α1-3)GalNAc(β1-4)-</figcaption></figure>

Heparan sulfate/Heparin

<figure><img src="image_15.png" /><figcaption>-GlcA(β1-4)GlcNAc(α1-4)-</figcaption></figure>

<figure><img src="image_16.png" /><figcaption>-IdoA(α1-4)GlcNAc(α1-4)-</figcaption></figure>

**Figure 6 Disaccharide units of GAGs: CS A is sulfated at C4 of GalNAc (pointed by an arrow).** CS C is sulfated at C6 of GalNAc (pointed by an arrow). In CS B (DS) GlcA is epimerized to IdoA, and can be sulfated at C4 or C6 of GalNAc and C2 of IdoA. HS includes GlcA and IdoA residues and can be sulfated at C2 of the uronic acid residue and at N, C6 and C3 of GlcN; heparin is basically constituted of IdoA-GlcN oversulfated disaccharides.

U/ml mutanolysin (Sigma-Aldrich) and incubated over-
night at 4°C. Cells were mechanically disrupted by re-
peated passage through a French press (SLM Aminco Inc),
the pellet was washed twice with buffer A and subjected
to overnight digestion with 5 mg/ml lysozyme in the
presence of protease inhibitors at 4°C, followed by incu-
bation with 5% Triton X-100 (Sigma-Aldrich) for 1 h at
room temperature. The final solution was centrifugated

at 10,000 rpm for 30 min and the supernatant was applied
to a 1 ml heparin affinity column (GE, Buckinghamshire,
England) connected to a FPLC system (GE). Bound pro-
teins were eluted with a continuous 0 – 2 M NaCl gradi-
ent in 50 mM Tris–HCl buffer (pH 7.5) and aliquots of
the protein fractions were used in HeLa/Lactobacillus ad-
herence assays. Those that interfered most were subjected
to anion exchange chromatography in a Q-sepharose FF
column (GE), eluted with a continuous 0 – 0.5 M NaCl gradient in 50 mM Tris-HCl buffer (pH 7.5) and the resulting fractions were subjected to adherence interference assays as described above. The protein concentrations were determined with the Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, USA) following the instructions of the manufacturer. SDS-PAGE [66] was performed in a "Miniprotean III" system (Bio-Rad, Hercules, USA). The proteins were stained with Comassie R-250 blue [70] or with a protein silver staining kit (GE). The band of interest was excised from the gels, digested with porcine trypsin and the resulting peptides were analyzed by MALDI-TOF/(MS) at the Proteomic Service of the *Centro Nacional de Biotecnología* (CNB-CSIC, Madrid).

Construction of expression plasmids and purification of
the oligopeptide permease A protein (OppA)

The *oppA* sequence of *L. salivarius* Lv72 [BankIt1609288 Lactobacillus KC703973] was amplified using primer pairs deduced from the *oppA* sequence of *L. salivarius* UCC118 (LSL_1882). The sequence encoding the OppA signal peptide was omitted to ease protein purification. The PCR product was purified and cloned into the vector pRSET-B digested with *NdeI* and *BamHI* (Fermentas, Thermo Scientific). The resulting plasmid was transformed to *E. coli* BL21 pLys (DE3)/pLysS cells, which were grown to an OD₆₀₀ of 0.6 at 37°C with shaking before addition of 1 mM IPTG (Fermentas, Thermo Scientific) and incubation was continued at 28°C with shaking overnight. The cultures were harvested, resuspended in 25 mM Tris-HCl (pH 7.5) containing 0.05% Triton-X100 and disrupted by sonication. The supernatant proteins were fractionated after passage through a heparin-affinity chromatography column as described above and the purified OppA protein was used for adhesion assays at concentrations ranging from 1 to 50 µg/ml.

**Statistical analysis**

Statistical analysis was performed using GraphPad Prism
Software version 5.00 for Windows (San Diego, California,
USA). The groups were compared using one-way analysis
of variance (ANOVA) followed by the student-Newman-
Keuls multiple comparison post hoc analysis. A p-value of
less than 0.05 was considered significant.

**Competing interests**

The authors declare that they have no competing interests.

Authors' contributions

RM carried out the adhesion assays, the enzymatic treatments and the isolation and identification of OppA protein and drafted the manuscript. CM participated in GAGs extraction and in the adhesion assays. SM carried out the clonage and purification of the OppA protein. ES and LQ conceived the study and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

**Acknowledgments**

This work was supported by the CICYT grant AGL2010-15097 from the Ministry of Science and Technology (Spain) and the FEDER Plan. CM and SE are holders of a scholarship and a contract, respectively, related to this project. RM was the holder of a scholarship from FICYT (Principado de Asturias). The University Institute of Oncology of Asturias is supported by Obra Social Cajastur, Asturias, Spain.

**Author details**

¹Área de Microbiología, Universidad de Oviedo, Julián Clavería 6 33006 Oviedo, Spain. ²Instituto Universitario de Biotecnología, Universidad de Oviedo, Oviedo, Spain. ³Instituto de Productos Lacteos de Asturias (IPLA-CSIC), Villaviciosa, Spain. ⁴Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.

Received: 23 March 2013 Accepted: 11 September 2013

Published: 17 September 2013

**References**

1. Martín R, Sanchez B, Suarez JE, Urdaci MC: Characterization of the adherence properties of human Lactobacilli strains to be used as vaginal probiotics. *FEMS Microbiol Lett* 2012, **328**:166-173.

2. Martín R, Soberón N, Vaneechoutte M, Flórez AB, Vázquez F, Suárez JE: Evaluation of newly isolated human vaginal lactobacilli and selection of probiotic candidates. *Int Microbiol* 2008, **11**:261-266.

3. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ: Vaginal microbiome of reproductive-age. *Proc Natl Acad Sci USA* 2011, **15**:108(1):4680-4687.

4. Reid G: Probiotic and prebiotic applications for vaginal health. J AOAC Int 2012, **95**(1):31-34.

5. Andreu A, Stapleton AE, Fennell CL, Hillier SL, Stamm WE: Hemagglutination, adherence, and surface properties of vaginal *Lactobacillus* species. *J Infect Dis* 1995, **171**:1237-1243.

6. Boris S, Suarez JE, Barbes C: Characterization of the aggregation promoting factor from *Lactobacillus gasseri*, a vaginal isolate. *J Appl Microbiol* 1997, **83**:413-420.

7. Vélez MP, De Keersmaecker SC, Vanderleyden J: Adherence factors of *Lactobacillus* in the human gastrointestinal tract. *FEMS Microbiol Lett* 2007, **276**:140-148.

8. Esko J, Lindahl U: Molecular diversity of heparan sulfate. *J Clin Invest* 2001, **108**:169-173.

9. Martín R, Soberón N, Vázquez F, Suárez JE: Vaginal microbiota: composition, protective role, associated pathologies, and therapeutic perspectives. *Enferm Infecc Microbiol Clin* 2008, **26**:160-167.

10. Sánchez B, Bressolier P, Urdaci MC: Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host. *FEMS Immunol Med Microbiol* 2008, **54**:1-17.

11. Tjalsma H, Lambooy L, Hermans PW, Swinkels DW: Shedding & shaving: disclosure of proteomic expression on a bacterial face. *Proteomics* 2008, **8**:1415-1428.

12. Munoz-Provincio D, Perez-Martinez G, Monedero V: Identification of surface proteins from Lactobacillus casei BL23 able to bind fibronectin and collagen. *Probiotics & Antimicro Prot* 2011, **3**:15-20.

13. Esko J, Lindahl U: Molecular diversity of heparan sulfate. *J Clin Invest* 2001, **108**:169-173.

14. Prydz K, Dalen KT: Synthesis and sorting of proteoglycans. *J Cell Sci* 2000, **113**:193-205.

15. Turnbull J, Powell A, Guimond S: Heparan sulpatem decoding a dynamic multifunctional cell regulator. *TRENDS Cell Biol* 2001, **11**:75-82.

16. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald M, Lincecum J, Zako M: Functions of cell surface heparan sulfate proteoglycans. *Annu Rev Biochem* 1999, **68**:729-777.

17. Rapraeger A, Jalkanen M, Bernfield M: Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. *J Cell Biol* 1986, **103**:2683-2696.

18. Schmidt G, Robenek H, Harrach B, Glössl J, Nolte V, Hörmann H, Richter H, Kresse H: Interaction of small dermal sulfate proteoglycan from fibroblasts with fibronectin. *J Cell Biol* 1987, **104**:1683-1691.
19. Kirn-Safran C, Farach-Carson MC, Carson DD: Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. *Cell Mol Life Sci* 2009, **66**:3421–3434.

20. Schaefer L, Schaefer RM: Proteoglycans: from structural compounds to signaling molecules. *Cell Tissue Res* 2010, **339**:237–246.

21. de Vries FP, Cole R, Dankert J, Frosch M, van Putten JP: *Neisseria meningitidis* producing the Opc adhesin binds epithelial cell proteoglycan receptors. *Mol Microbiol* 1998, **27**:1203–1212.

22. Chen T, Belland RJ, Wilson J, Swanson J: Adherence of pilus- Opa+ gonococci to epithelial cells in vitro involves heparan sulfate. *J Exp Med* 1995, **182**:511–517.

23. Grant CC, Bos MP, Belland RJ: Proteoglycan receptor binding by *Neisseria gonorrhoeae* MS11 is determined by the HV-1 region of OpaA. *Mol Microbiol* 1999, **32**:233–242.

24. Dupres V, Verbelen C, Raze D, Lafont F, Dufrêne YF: Force spectroscopy of the interaction between mycobacterial adhesins and heparan sulphate proteoglycan receptors. *Chemphyschem* 2009, **10**:1672–1675.

25. Sava IG, Zhang F, Toma I, Theilacker C, Li B, Baumert TF, Holst O, Linhardt RJ, Huebner J: Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells. *J Biol Chem* 2009, **284**:18194–18201.

26. Asano K, Kakizaki I, Nakane A: Interaction of *Listeria monocytogenes* autolysin amidase with glycosaminoglycans promotes listerial adhesion to mouse hepatocytes. *Biochimie* 2012, **94**:1291–1299.

27. Henry-Stanley M, Hess DJ, Erlandsen SL, Wells CL: Ability of the heparin sulfate proteoglycan syndecan-1 to participate in bacterial translocation across the intestinal epithelial barrier. *SHOCK* 2005, **6**:571–576.

28. Castañeda-Roldan EI, Avelino-Flores F, Dall'Agnol M, Freer E, Cedillo L, Dornand J, Girò JA: Adherence of *Brucella* to human epithelial cells and macrophages is mediated by sialic acid residues. *Cell Microbiol* 2004, **6**:435–445.

29. Fleckenstein JM, Holland JT, Hasty DL: Interaction of an uuter membrane protein of enterotoxigenic *Escherichia coli* with cell surface heparan sulfate proteoglycans. *Infect Immun* 2002, **70**:1530–1537.

30. Wuppermann FN, Hegemann JH, Jantos CA: Heparan sulfate-like glycosaminoglycan is a cellular receptor for *Chlamydia pneumoniae*. *J Infect Dis* 2001, **184**:181–187.

31. Cywes C, Stamenkovic I, Wessels MR: CD44 as a receptor for colonization of the pharynx by group A *Streptococcus*. *J Clin Invest* 2000, **106**:995–1002.

32. Cywes C, Wessels MR: Group A *Streptococcus* tissue invasion by CD44-mediated cell signalling. *Nature* 2001, **414**:648–652.

33. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M: Human papillomavirus infection requires cell surface heparan sulfate. *J Virol* 2001, **75**:1565–1570.

34. Akula SM, Wang FZ, Vieira J, Chandran B: Human herpesvirus 8 interaction with target cells involves heparan sulfate. *Virology* 2001, **282**:245–255.

35. Bobardt MD, Saphire AC, Hung HC, Yu X, Van der Schueren B, Zhang Z, David G, Gallay PA: Syndecan captures, protects, and transmits HIV to T lymphocytes. *Immunity* 2003, **18**:27–39.

36. Carruthers VB, Hakansson S, Giddings OK, Sibley LD: *Toxoplasma gondii* uses sulfated proteoglycans for substrate and host cell attachment. *Infect Immun* 2000, **68**:4005–4011.

37. Love DC, Esko JD, Mosser DM: A heparin-binding activity on *Leishmania* amastigotes which mediates adhesion to cellular proteoglycans. *J Cell Biol* 1993, **123**:759–766.

38. Coppi A, Tewari R, Bishop JR, Bennett BL, Lawrence R, Esko JD, Bilker O, Sinnis P: Heparan sulfate proteoglycans provide a signal to *Plasmodium* sporozoites to stop migrating and productively invade host cells. *Cell Host Microbe* 2007, **2**:316–327.

39. Almeida RA, Fang W, Oliver SP: Adherence and internalization of *Streptococcus uberis* to bovine mammary epithelial cells are mediated by host cell proteoglycans. *FEMS Microbiol Lett* 1999, **177**:313–317.

40. Hess DJ, Henry Stanley MJ, Erlandsen SL, Wells CL: Heparan sulfate proteoglycans mediate *Staphylococcus aureus* interactions with intestinal epithelium. *Med Microbiol Immunol* 2006, **195**:133–141.

41. Landry JJ, Pyl PT, Rausch T, Zichner T, Tekkedil MM, Stütz AM, Jauch A, Aiyar RS, Pau G, Delhomme N, Gagneur J, Korbel JO, Huber W, Steinmetz LM: G3 (Bethesda). The genomic and transcriptomic landscape of a *HeLa* Cell Line 2013, **3**(8):1213–1224. doi: 10.1534/g3.113.005777.

42. Falkow S: Bacterial entry into eukaryotic cells. *Cell* 1991, **65**(7):1099–1102.

43. Finlay BB: Cell adhesion and invasion mechanisms in microbial pathogenesis. *Curr Opin Cell Biol* 1990, **2**:815–820.

44. Westerlund B, Korhonen TK: Bacterial proteins binding to the mammalian extracellular matrix. *Mol Microbiol* 1993, **9**:687–694.

45. Muñoz-Provencio D, Pérez-Martinez G, Monedero V: Characterization of a fibronectin-binding protein from *Lactobacillus casei* BL23. *J Appl Microbiol* 2010, **108**:1050–1059.

46. Nagy E, Froman G, Mardh PA: Fibronectin binding of *Lactobacillus* species isolated from women with and without bacterial vaginosis. *J Med Microbiol* 1992, **37**:38–42.

47. Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P, Holmes KK: Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. *J Infect Dis* 1996, **174**:1058–1063.

48. Courtney HS, Ofek I, Penfound T, Nizet V, Pence MA, Kreikemeyer B, Podbielski A, Hasty DL, Dale JB: Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in *Sreptococcus pyogenes*. *PLoS One* 2009, **4**:e4166.

49. Mulley B, Forster MJ: Conformation and dynamics of heparin and heparan sulfate. *Glycobiology* 2000, **10**:1147–1156.

50. Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CLR, Dierks T: The heparanome-the enigma of encoding and decoding heparan sulfate sulfation. *J. of Biotechnology* 2007, **129**:290–307.

51. Alvarez-Domínguez C, Vázquez-Boland JA, Carrasco-Marín E, López-Mato P, Leyva-Cobian F: Host cell heparan sulfate proteoglycans mediate attachment and entry of *Listeria monocytogenes*, and the listerial surface protein ActA is involved in heparan sulfate receptor cognition. *Infect Immun* 1997, **65**:78–88.

52. Srinoulprasert Y, Kongtawelert P, Chaiyaroj SC: Chondroitin sulfate B and heparin mediate adhesion of *Penicillium mameffi* conidia to host extracellular matrices. *Microb Pathog* 2006, **40**:126–132.

53. Tonnaer ELGM, Hafmans TG, Van Kuppevelt TH, Sanders EAM, Verweij PE, Curfs JHAJ: Involvement of glycosaminoglycans in the attachment of pneumococci to nasopharyngeal epithelial cells. *Microbes Infect* 2006, **8**:316–322.

54. Zaretzky FR, Pearce-Pratt R, Phillips DM: Sulfated polyanions block *Chlamydia trachomatis* infection of cervix-derived human epithelia. *Infect Immun* 1995, **63**:3520–3526.

55. Plotkowski MC, Costa AO, Morandi V, Barbosa HS, Nader HB, De Bentzmann S, Puchelle E: Role of heparan sulfate proteoglycans as potential receptors for non-piliated *Pseudomonas aeruginosa* adherence to non-polarised airway epithelial cells. *J Med Microbiol* 2001, **50**:183–190.

56. Fischer JR, LeBlanc KT, Leong JM: Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. *Infect Immun* 2006, **74**:435–441.

57. Breiner DD, Fahey M, Salvador R, Novakova J, Coburn J: *Leptospira interrogans* binds to human cell surface receptors including proteoglycans. *Infect Immun* 2009, **77**:5528–5536.

58. Caterson B, Mahmoodian F, Sorrell JM, Hardingham TE, Bayliss MT, Carney SL, Ratcliffe A, Muir H: Modulation of native chondroitin sulphate structure in tissue development and in disease. *J Cell Sci* 1990, **97**:411–417.

59. Lindahl U, Kusche-Gullberg M, Kjellén L: Regulated diversity of heparan sulfate. *J Biol Chem* 1998, **273**:24979–24982.

60. Peltoniemi K, Vesanto E, Palva A: Genetic characterization of an oligopeptide transport system from *Lactobacillus delbrueckii* subsp. *bulgaricus*. *Arch Microbiol* 2002, **177**:457–467.

61. Fenno JC, Tamura M, Hannam PM, Wong GW, Chan RA, McBride BC: Identification of a Treponema denticola OppA homologue that binds host proteins present in the subgingival environment. *Infect Immun* 2000, **68**:1884–1892.

62. Henrich B, Hopfe M, Kitzerow A, Hadding U: The adherence-associated lipoprotein P100, encoded by an opp operon structure, functions as the oligopeptide-binding domain OppA of a putative oligopeptide transport system in Mycoplasma hominis. *J Bacteriol* 1999, **181**:4873–4878.

63. Hopfe M, Dahlmanns T, Henrich B: In *Mycoplasma hominis* the OppA-mediated cytoadhesion depends on its ATPase activity. *BMC Microbiol* 2011, **11**:185.

64. Miyoushi Y, Okada S, Uchimura T, Saoh E: A mucus adhesion promotin protein, MapA, mediates the adhesion of *Lactobacillus reuteri* to Caco-2 human intestinal epithelial cells. *Biosci Biotechnol Biochem* 2006, **70**:1622–1628.

65. Dasgupta A, Sureka K, Mitra D, Saha B, Sanyal S, Das AK, Chakrabarti P, Jackson M, Cicquel B, Kundu M, Basu J: An oligopeptide transporter of *Mycobacterium tuberculosis* regulates cytokine release and apoptosis of infected macrophages. *PLoS One* 2010, **5**:e12225.
66. Berntsson RP, Doeven MK, Fusetti F, Duurkens RH, Sengupta D, Marrink SJ, Thunnissen AM, Poolman B, Slotboom DJ: *The structural basis for peptide selection by the transport receptor OppA*. EMBO J 2009, **28**(9):1332–1340.

67. Tallon R, Arias S, Bressollier P, Urdaci MC: Strain and matrix-dependent adhesion of *Lactobacillus plantarum* is mediated by proteinaceous bacterial compounds. *J Appl Microbiol* 2007, **102**:442–451.

68. Hulme EC, Birdsall NJM: Strategy and tactics in receptor-binding studies. In *Receptor-Ligand Interactions. A Practical Approach*. Edited by Hulme EC. New York: IRL Press at Oxford University Press; 1992:63–176.

69. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. *Nature* 1970, **227**:680–685.

70. Sambrook J, Fritsch EF, Maniatis T: Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989:1,626. soft cover.

doi:10.1186/1471-2180-13-210

Cite this article as: Martín *et al*.: Surface glycosaminoglycans mediate adherence between HeLa cells and *Lactobacillus salivarius* Lv72. *BMC Microbiology* 2013 **13**:210.

Submit your next manuscript to BioMed Central
and take full advantage of:

* Convenient online submission

* Thorough peer review

* No space constraints or color figure charges

* Immediate publication on acceptance

* Inclusion in PubMed, CAS, Scopus and Google Scholar

* Research which is freely available for redistribution